Risperidone ODT 2mg Tablets

Manufacturer CADISTA Active Ingredient Risperidone Orally Disintegrating Tablets(ris PER i done) Pronunciation ris PER i done
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat schizophrenia.It is used to treat bipolar disorder.It is used to treat irritation that happens with autistic disorder.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antipsychotic
đŸ§Ŧ
Pharmacologic Class
Atypical antipsychotic; Benzisoxazole derivative; Serotonin-dopamine antagonist
🤰
Pregnancy Category
C
✅
FDA Approved
Dec 1993
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Risperidone is a medication used to treat certain mental health conditions like schizophrenia, bipolar disorder, and irritability related to autism. It works by helping to balance certain natural chemicals in the brain. The ODT (Orally Disintegrating Tablet) form dissolves quickly on your tongue, making it easier to take.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, as directed. Continue taking it as prescribed by your doctor or healthcare provider, even if you're feeling well.

When taking your medication, make sure to:

Remove it from the blister pack only when you're ready to take it
Take it immediately after opening the blister pack
Do not store the removed medication for future use
Use dry hands to remove the tablet from the foil
Place the tablet on your tongue and let it dissolve; water is not necessary
Do not swallow the tablet whole, chew, break, or crush it

Storing and Disposing of Your Medication

To store your medication properly:

Keep it at room temperature, protected from light
Store it in a dry place, avoiding bathrooms
Keep all medications in a safe location, out of reach of children and pets

When disposing of your medication:

Throw away any unused or expired medication
Do not flush it down the toilet or pour it down the drain unless instructed to do so
Check with your pharmacist for guidance on proper disposal
* Consider participating in local drug take-back programs

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Take exactly as prescribed, do not stop suddenly without consulting your doctor.
  • Do not push the ODT tablet through the foil; peel back the foil and gently remove the tablet.
  • Place the tablet on your tongue immediately after opening the blister pack. It will dissolve quickly and can be swallowed with or without water.
  • Avoid alcohol and other CNS depressants as they can increase drowsiness.
  • Be aware of potential for dizziness or lightheadedness, especially when standing up quickly (orthostatic hypotension).
  • Monitor for weight gain and discuss healthy diet and exercise with your doctor.
  • Report any unusual or uncontrollable movements (especially of the face, tongue, or limbs) to your doctor immediately.
  • Stay hydrated, especially in hot weather, to prevent overheating.
  • Regularly attend follow-up appointments and blood tests as advised by your doctor.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For schizophrenia, typically 2-4 mg/day in 1-2 divided doses. For bipolar mania, typically 2-3 mg/day.
Dose Range: 0.5 - 16 mg

Condition-Specific Dosing:

schizophrenia: Initial 0.5-2 mg/day, target 4-8 mg/day. Max 16 mg/day.
bipolar_mania: Initial 2-3 mg/day, target 1-6 mg/day. Max 6 mg/day.
autistic_irritability: Initial 0.25 mg BID, titrate to 0.5 mg BID for patients <20 kg; 0.5 mg BID for patients â‰Ĩ20 kg, titrate to 1 mg BID. Max 3 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For irritability associated with autistic disorder (5-16 years): Initial 0.25 mg/day for patients <20 kg, 0.5 mg/day for patients â‰Ĩ20 kg. Titrate slowly based on response and tolerability. Max 3 mg/day.
Adolescent: For schizophrenia (13-17 years): Initial 0.5 mg/day, titrate to 3 mg/day. Max 6 mg/day. For bipolar mania (10-17 years): Initial 0.5 mg/day, titrate to 1-2.5 mg/day. Max 6 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment for mild impairment, but monitor closely.
Moderate: Initial 0.5 mg BID, titrate slowly. Max 1.5 mg BID.
Severe: Initial 0.5 mg BID, titrate slowly. Max 1.5 mg BID.
Dialysis: Considerations: Risperidone is not significantly removed by hemodialysis. Follow severe impairment dosing.

Hepatic Impairment:

Mild: No specific adjustment for mild impairment, but monitor closely.
Moderate: Initial 0.5 mg BID, titrate slowly. Max 1.5 mg BID.
Severe: Initial 0.5 mg BID, titrate slowly. Max 1.5 mg BID.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Risperidone is a selective monoaminergic antagonist with high affinity for serotonin 5-HT2A and dopamine D2 receptors. It also antagonizes alpha1-adrenergic, alpha2-adrenergic, and histaminergic H1 receptors. Its antipsychotic activity is believed to be mediated through a combination of dopamine D2 and serotonin 5-HT2A receptor antagonism.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 70% (oral solution/tablet)
Tmax: Risperidone: 1 hour; 9-hydroxyrisperidone: 3-17 hours (extensive metabolizers)
FoodEffect: Food does not affect the rate or extent of absorption.

Distribution:

Vd: 1-2 L/kg
ProteinBinding: Risperidone: ~90%; 9-hydroxyrisperidone: ~77%
CnssPenetration: Yes

Elimination:

HalfLife: Risperidone: Approximately 3 hours; 9-hydroxyrisperidone: Approximately 21-24 hours (extensive metabolizers), ~30 hours (poor metabolizers)
Clearance: Not readily available as a single rate, but primarily renal excretion.
ExcretionRoute: Renal (70%), Fecal (14%)
Unchanged: Less than 10% (risperidone), 35-45% (total active moiety)
âąī¸

Pharmacodynamics

OnsetOfAction: Within days to weeks for full therapeutic effect, some symptom improvement may be seen earlier.
PeakEffect: Varies by indication and individual, generally within 1-2 weeks of stable dosing.
DurationOfAction: Due to long half-life of active metabolite, allows for once or twice daily dosing.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperidone is not approved for the treatment of patients with dementia-related psychosis.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion or feeling sleepy
+ Unusual thirst or hunger
+ Frequent urination or flushing
+ Rapid breathing or breath that smells like fruit
Severe dizziness or fainting
Changes in behavior or mood
Shakiness, difficulty moving, or stiffness
Urination problems (inability to pass urine or changes in urine output)
Difficulty swallowing or speaking
Trouble focusing
Seizures
Changes in vision
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, such as:
+ Enlarged breasts or nipple discharge
+ Erectile dysfunction or menstrual changes
+ Decreased sex drive or ejaculation problems
Prolonged or painful erections (lasting more than 4 hours): seek medical attention immediately to prevent long-term sexual dysfunction

Serious but Rare Side Effects

Neuroleptic malignant syndrome (NMS): a potentially life-threatening condition. Seek medical help right away if you experience:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion or changes in thinking
+ Rapid or irregular heartbeat
+ Excessive sweating
Low white blood cell count: increases the risk of infection. Inform your doctor if you have a history of low white blood cell count. Seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia: a severe muscle disorder that may be irreversible. Seek medical help if you experience:
+ Uncontrolled body movements
+ Tongue, face, mouth, or jaw problems (e.g., tongue sticking out, puffing cheeks, mouth puckering, or chewing)

Other Possible Side Effects

While many people may not experience side effects or only have mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or persist:

Weight gain
Restlessness
Dizziness, drowsiness, tiredness, or weakness
Anxiety
Constipation, diarrhea, stomach pain, upset stomach, or vomiting
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
Back, muscle, arm, or leg pain

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever, muscle stiffness, confusion, sweating, or fast/irregular heartbeat (signs of Neuroleptic Malignant Syndrome)
  • Uncontrolled movements of your face, tongue, or other body parts (signs of Tardive Dyskinesia)
  • Dizziness, lightheadedness, or fainting, especially when standing up
  • Difficulty swallowing or breathing
  • Increased thirst, increased urination, increased hunger, or unexplained weight loss (signs of high blood sugar)
  • Breast enlargement, nipple discharge, missed periods, or sexual problems (signs of high prolactin levels)
  • Sudden weakness or numbness on one side of the body, slurred speech, or vision changes (signs of a stroke, especially in elderly with dementia)
  • Severe skin rash or allergic reaction
  • Thoughts of self-harm or worsening depression
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist identify potential interactions between this medication and other substances you are taking.
* Any health problems you have, as this medication may interact with certain conditions.

To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, be cautious when driving or performing tasks that require your full attention, as it may affect your alertness. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when climbing stairs.

You may not experience the full effects of this medication for several weeks. Additionally, be aware that medications like this one have been associated with increased risks of high blood sugar, diabetes, high cholesterol, and weight gain, which may contribute to heart and brain blood vessel disease.

As directed by your doctor, monitor your blood sugar levels regularly. Also, follow your doctor's instructions for having blood work checked, and discuss any concerns or questions you may have with your doctor.

Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness, consult with your doctor.

In hot weather or during physical activity, be mindful of your fluid intake to prevent dehydration. Drink plenty of fluids to stay hydrated.

This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls and related injuries, such as fractures.

If you have phenylketonuria (PKU), consult your doctor, as some products contain phenylalanine.

Older adults with dementia who take medications like this one have a higher risk of experiencing strokes, which can be fatal. Note that this medication is not approved for treating dementia-related mental health issues.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

This medication may affect fertility, but this effect is reversible once the medication is discontinued. If you have concerns, discuss them with your doctor.

Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is crucial to discuss the potential benefits and risks of this medication for both you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or sedation
  • Fast or irregular heartbeat
  • Low blood pressure (dizziness, fainting)
  • Extrapyramidal symptoms (severe muscle stiffness, tremor, uncontrolled movements)
  • Seizures
  • Coma

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. In the US, you can also call a poison control center at 1-800-222-1222.

Drug Interactions

🔴

Major Interactions

  • CNS depressants (e.g., opioids, benzodiazepines, alcohol): Increased sedation and CNS depression.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Increased risk of arrhythmias.
  • Dopamine agonists (e.g., levodopa, bromocriptine): Antagonism of effects.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): Can increase risperidone plasma levels and active moiety.
🟡

Moderate Interactions

  • CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin): Can decrease risperidone and active moiety plasma levels.
  • CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): Can increase risperidone plasma levels.
  • Antihypertensives: Enhanced hypotensive effects.
  • Diuretics (especially in elderly with dementia): Increased risk of mortality and cerebrovascular events.
  • Cimetidine, ranitidine: May increase risperidone bioavailability (minor effect).
đŸŸĸ

Minor Interactions

  • Lithium: No significant pharmacokinetic interaction, but monitor for additive CNS effects.
  • Valproate: No significant pharmacokinetic interaction, but monitor for additive CNS effects.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Complete Blood Count (CBC)

Rationale: To assess for blood dyscrasias (e.g., leukopenia, neutropenia) which are rare but serious side effects.

Timing: Prior to initiation

Electrolytes (Na, K, Mg, Ca)

Rationale: To assess for electrolyte imbalances that could predispose to cardiac arrhythmias, especially with QTc prolongation risk.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, especially important for a hepatically metabolized drug.

Timing: Prior to initiation

Renal Function (BUN, Creatinine)

Rationale: To assess baseline renal function, as dose adjustments are needed in renal impairment.

Timing: Prior to initiation

Fasting Plasma Glucose

Rationale: To assess for baseline hyperglycemia, as atypical antipsychotics can cause metabolic changes.

Timing: Prior to initiation

Lipid Panel (Fasting)

Rationale: To assess for baseline dyslipidemia, as atypical antipsychotics can cause metabolic changes.

Timing: Prior to initiation

Weight, Height, Waist Circumference

Rationale: To establish baseline for monitoring weight gain and metabolic syndrome risk.

Timing: Prior to initiation

Blood Pressure (BP) and Heart Rate (HR)

Rationale: To assess for baseline orthostatic hypotension risk and cardiovascular status.

Timing: Prior to initiation

Electrocardiogram (ECG)

Rationale: To assess for baseline QTc interval and other cardiac abnormalities, especially in patients with cardiac risk factors.

Timing: Prior to initiation (consider for high-risk patients)

Prolactin Levels

Rationale: To assess baseline, as risperidone can cause hyperprolactinemia.

Timing: Prior to initiation (consider for patients with symptoms or risk factors)

Movement Disorder Assessment (e.g., AIMS, SAS, BARS)

Rationale: To establish baseline for monitoring extrapyramidal symptoms (EPS) and tardive dyskinesia (TD).

Timing: Prior to initiation

📊

Routine Monitoring

Weight, Waist Circumference

Frequency: Monthly for first few months, then quarterly

Target: Maintain stable weight; minimize increase in waist circumference

Action Threshold: Significant weight gain (>5% baseline) or rapid increase in waist circumference warrants intervention (diet, exercise, consider alternative).

Fasting Plasma Glucose

Frequency: At 3 months, then annually

Target: <100 mg/dL

Action Threshold: Fasting glucose â‰Ĩ100 mg/dL (prediabetes) or â‰Ĩ126 mg/dL (diabetes) warrants further evaluation and management.

Lipid Panel (Fasting)

Frequency: At 3 months, then annually

Target: LDL <100 mg/dL, HDL >40 mg/dL (men), >50 mg/dL (women), Triglycerides <150 mg/dL

Action Threshold: Significant dyslipidemia warrants further evaluation and management.

Blood Pressure (BP) and Heart Rate (HR)

Frequency: At each visit, especially during dose titration

Target: Within normal limits, no significant orthostatic changes

Action Threshold: Persistent orthostatic hypotension (drop of â‰Ĩ20 mmHg systolic or â‰Ĩ10 mmHg diastolic) or significant hypertension warrants intervention.

Movement Disorder Assessment (e.g., AIMS, SAS, BARS)

Frequency: Quarterly to annually

Target: No new or worsening EPS/TD

Action Threshold: Emergence or worsening of EPS/TD warrants dose adjustment, anticholinergic medication, or consideration of alternative antipsychotic.

Prolactin Levels

Frequency: Annually or if symptoms of hyperprolactinemia (e.g., amenorrhea, galactorrhea, gynecomastia, sexual dysfunction) develop.

Target: Within normal limits

Action Threshold: Symptomatic hyperprolactinemia warrants evaluation and potential intervention (dose reduction, alternative medication, or specific treatment).

ECG

Frequency: Periodically, especially if cardiac risk factors, electrolyte abnormalities, or symptoms of arrhythmia develop.

Target: QTc <450 ms (men), <470 ms (women)

Action Threshold: QTc prolongation >500 ms or increase of >60 ms from baseline warrants immediate evaluation and potential discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Sedation/Somnolence
  • Dizziness/Orthostatic Hypotension
  • Extrapyramidal Symptoms (tremor, rigidity, akathisia, dystonia)
  • Tardive Dyskinesia (involuntary movements, especially of face and tongue)
  • Weight gain
  • Changes in appetite or thirst
  • Symptoms of hyperglycemia (increased thirst, urination, hunger)
  • Symptoms of hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia, sexual dysfunction)
  • Changes in mood or behavior (e.g., agitation, aggression, suicidal ideation)
  • Signs of Neuroleptic Malignant Syndrome (fever, muscle rigidity, altered mental status, autonomic instability)
  • Signs of cerebrovascular events (sudden weakness, numbness, speech changes, vision changes) in elderly dementia patients

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for major malformations based on available atypical antipsychotic data.
Second Trimester: Limited data, continued monitoring for fetal growth and development.
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms in neonates (e.g., agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder). Monitor neonates for these symptoms.
🤱

Lactation

Risperidone and its active metabolite are excreted in human breast milk. Weigh the benefits of breastfeeding against the potential risks to the infant. Monitor breastfed infants for sedation, poor feeding, and developmental milestones.

Infant Risk: L3 (Moderately safe) - Potential for sedation, irritability, poor feeding, and developmental delay. Consider lowest effective dose and monitor infant.
đŸ‘ļ

Pediatric Use

Approved for irritability associated with autistic disorder (5-16 years), schizophrenia (13-17 years), and bipolar mania (10-17 years). Dosing is weight-based and titrated slowly. Monitor closely for weight gain, metabolic changes, and EPS.

👴

Geriatric Use

Elderly patients, especially those with dementia-related psychosis, are at increased risk of mortality and cerebrovascular adverse events (e.g., stroke, transient ischemic attack). Risperidone is not approved for dementia-related psychosis. Start with lower doses and titrate slowly due to potential for increased sensitivity to side effects (e.g., orthostatic hypotension, sedation, EPS).

Clinical Information

💎

Clinical Pearls

  • Risperidone ODT should be handled with dry hands and placed on the tongue immediately after opening the blister pack. It dissolves rapidly and can be swallowed with or without liquid.
  • Due to the risk of orthostatic hypotension, especially at initiation and during dose escalation, advise patients to rise slowly from a sitting or lying position.
  • Monitor for hyperprolactinemia, which can lead to symptoms like galactorrhea, amenorrhea, gynecomastia, and sexual dysfunction. Consider prolactin levels if symptoms arise.
  • Be vigilant for metabolic side effects including weight gain, hyperglycemia, and dyslipidemia. Regular monitoring of these parameters is crucial.
  • The active metabolite, 9-hydroxyrisperidone (paliperidone), contributes significantly to the drug's effects and has a much longer half-life, influencing dosing frequency and steady-state attainment.
  • Patients who are CYP2D6 poor metabolizers may have higher risperidone levels and lower 9-hydroxyrisperidone levels, but the total active moiety generally remains similar, though individual responses may vary.
🔄

Alternative Therapies

  • Other atypical antipsychotics (e.g., Olanzapine, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, Brexpiprazole)
  • Typical antipsychotics (e.g., Haloperidol, Chlorpromazine) - generally less preferred due to higher EPS risk
  • Mood stabilizers (e.g., Lithium, Valproate, Carbamazepine) for bipolar disorder
  • SSRIs/SNRIs for co-occurring anxiety/depression (if appropriate and not primary indication)
💰

Cost & Coverage

Average Cost: Varies, typically $10-$50 per 30 tablets (generic 2mg ODT)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.